A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL WITH VEGFR2-EPITOPE PEPTIDE AND GEMCITABINE FOR PATIENTS WITH LOCALLY ADVANCED, METASTATIC, OR UNRESECTABLE PANCREATIC CANCER: PEGASUS-PC STUDY

被引：0
|
作者：
Yamaue, H. [1 ]
Miyazawa, M. [1 ]
Mizuno, N. [2 ]
Okusaka, T. [3 ]
Fukutomi, A. [4 ]
Ishii, H.
Ohkawa, S. [5 ]
Furukawa, M. [6 ]
Maguchi, H. [7 ]
Ikeda, M. [8 ]
Nishio, K. [9 ]
Ohashi, Y. [10 ]
Tsunoda, T.
机构：
[1] Wakayama Med Univ Hosp, Dept Surg 2, Wakayama, Japan
[2] Aichi Canc Ctr Hosp, Dept Gastroenterol, Aichi, Japan
[3] Natl Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[4] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[5] Kanagawa Canc Ctr Hosp, Div Hepatobiliary & Pancreat Oncol, Kanagawa, Japan
[6] Natl Hosp Org Kyushu Canc Ctr, Dept Hepatobiliary Pancreatol, Fukuoka, Japan
[7] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan
[8] Natl Canc Ctr Hosp E, Div Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[9] Kinki Univ, Sch Med, Dept Genome Biol, Higashiosaka, Osaka 577, Japan
[10] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Tokyo 1138654, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：74 / 74
页数：1
相关论文
共 50 条
  • [31] Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
    Jung Yong Hong
    Eun Mi Nam
    Jeeyun Lee
    Joon Oh Park
    Sang-Cheol Lee
    Seo-Young Song
    Seong Ho Choi
    Jin Seok Heo
    Se Hoon Park
    Ho Yeong Lim
    Won Ki Kang
    Young Suk Park
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 125 - 130
  • [32] A phase 3 randomized, double-blind, placebo-controlled, multicenter, global study of durvalumab with and after chemoradiotherapy in patients with locally advanced, unresectable esophageal squamous cell carcinoma: KUNLUN
    Wang, Luhua
    Chen, Ming
    Kato, Ken
    Wyrwicz, Lucjan
    Smyth, Elizabeth Catherine
    Jiang, Anastasia
    Zhang, Di
    Robbins, Scott H.
    He, Philip
    Negro, Alejandra
    Saba, Nabil F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [33] Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
    Nie, Shuchang
    Su, Yingyu
    Lu, Lu
    Jing, Yanhua
    Jiang, Zenghua
    Xu, Yangxian
    Wu, Tingting
    Zhong, Yi
    Wu, Hao
    Chen, Junming
    Ruan, Ming
    Zheng, Lan
    Wang, Liyu
    Gong, Yabin
    Ji, Guang
    Xu, Hanchen
    FRONTIERS IN MEDICINE, 2025, 12
  • [34] Melatonin in Patients with Cancer Receiving Chemotherapy: A Randomized, Double-blind, Placebo-controlled Trial
    Sookprasert, Aumkhae
    Johns, Nutjaree Pratheepawanit
    Phunmanee, Anakapong
    Pongthai, Parichart
    Cheawchanwattana, Areewan
    Johns, Jeff
    Konsil, Julraht
    Plaimee, Preeyaporn
    Porasuphatana, Supatra
    Jitpimolmard, Suthiphan
    ANTICANCER RESEARCH, 2014, 34 (12) : 7327 - 7337
  • [35] A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naive Pancreatic Adenocarcinoma
    Cohen, Steven J.
    Zalupski, Mark M.
    Conkling, Paul
    Nugent, Francis
    Ma, Wen Wee
    Modiano, Manuel
    Pascual, Rolan
    Lee, Fa Chyi
    Wong, Lucas
    Hersh, Evan
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 230 - 235
  • [36] Prednisone for patients with recurrent implantation failure: study protocol for a double-blind, multicenter, randomized, placebo-controlled trial
    Lu, Yao
    Yan, Junhao
    Liu, Jiayin
    Tan, Jichun
    Hong, Yan
    Wei, Daimin
    Chen, Zi-jiang
    Sun, Yun
    TRIALS, 2020, 21 (01)
  • [37] Prednisone for patients with recurrent implantation failure: study protocol for a double-blind, multicenter, randomized, placebo-controlled trial
    Yao Lu
    Junhao Yan
    Jiayin Liu
    Jichun Tan
    Yan Hong
    Daimin Wei
    Zi-jiang Chen
    Yun Sun
    Trials, 21
  • [38] A randomized phase II, double-blind study to evaluate the efficacy and safety of galunisertib plus gemcitabine (GG) or gemcitabine plus placebo (GP) in patients with unresectable pancreatic cancer (PC)
    Melisi, Davide
    Garcia-Carbonero, Rocio
    Macarulla, Teresa
    Pezet, Denis
    Deplanque, Gael
    Fuchs, Martin
    Trojan, Joerg
    Oettle, Helmut
    Kozloff, Mark
    Cleverly, Ann
    Gueorguieva, Ivelina
    Desaiah, Durisala
    Lahn, Michael M.
    Al Blunt
    Benhadji, Karim A.
    Tabernero, Josep
    CANCER RESEARCH, 2016, 76
  • [39] Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo-controlled, double-blind trial
    Lebrec, Didier
    Thabut, Dominique
    Oberti, Frederic
    Perarnau, Jean-Marc
    Condat, Bertrand
    Barraud, Helene
    Saliba, Faouzi
    Carbonell, Nicolas
    Renard, Philippe
    Ramond, Marie-Jose
    Moreau, Richard
    Poynard, Thierry
    HEPATOLOGY, 2007, 46 (04) : 249A - 250A
  • [40] A Double-Blind, Randomized, Placebo-Controlled Trial of Panax Ginseng for Cancer-Related Fatigue in Patients With Advanced Cancer
    Yennurajalingam, Sriram
    Tannir, Nizar M.
    Williams, Janet L.
    Lu, Zhanni
    Hess, Kenneth R.
    Frisbee-Hume, Susan
    House, Helen L.
    Lim, Zita Dubauskas
    Lim, Kyu-Hyoung
    Lopez, Gabriel
    Reddy, Akhila
    Azhar, Ahsan
    Wong, Angelique
    Patel, Sunil M.
    Kuban, Deborah A.
    Kaseb, Ahmed Omar
    Cohen, Lorenzo
    Bruera, Eduardo
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (09): : 1111 - 1120
12345